The 29th Annual Meeting of the Japanese Society for Vaccinology/The 66th Annual Meeting of the Japanese Society of Clinical Virology

*Yurie Yoshida^1,2, Noriko Ogasawara^1,2, Soh Yamamoto¹, Junpei Ohtsuka³, Tomomi Ohtsuka³, Kyoko Ito³, Masayuki Fukumura³, Tetsuya Nosaka⁴, Kenichi Takano², Shin-ichi Yokota¹ (1. Division of Microbiology, Department of Infectious Diseases, Sapporo Medical University School of Medicine, 2. Department of Otolaryngology-Head and Neck Surgery, Sapporo Medical University School of Medicine, 3. BioComo Inc., 4. Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine)

*Takashi Ito^1,2, Ayumi Saito¹, Tetsuo Nakayama², Kazuhiko Katayama² (1. Department of Pediatrics, Kitasato university school of medicine, 2. Omura Satoshi Memorial Institute, Kitasato University)

*Fumiyo Ogawa^1,2, Rie Doi^1,2, Shinya Okamura^1,2, Takeshi Sugimoto^1,2, Manae Morishima², Youichi Suzuki³, Takashi Nakano³, Hirotaka Ebina^1,2 (1. The Research Foundation for Microbial Diseases of Osaka University, 2. Virus Vaccine group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, University of Osaka, 3. Department of Microbiology and Infection Control, Faculty of Medicine, Osaka Medical and Pharmaceutical University)

*Kotaro Taniguchi^1,2, Kota Senpuku^1,2, Mika Hirose³, Tatsuya Karaki^2,4, Yuta Kunishima^2,4, Toshiro Hirai^1,2,5,6, Takayuki Kato^3,6, Yasuo Yoshioka^1,2,4,5,6 (1. Laboratory of Nano-design for Innovate Drug Development, Graduate School of Pharmaceutical Sciences, The University of Osaka, 2. Vaccine Creation Group,Research Institute for Microbial Diseases, The University of Osaka, 3. Institute for Protein Research, The University of Osaka, 4. The Research Foundation for Microbial Diseases of Osaka University, 5. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, 6. Center for Advanced Modalities and DDS, The University of Osaka)

*Kenichi Otaki¹, Fumihiro Yasui², Hirohito Ishigaki¹, Naoko Kitagawa¹, Koji Ishii³, Michinori Kohara², Yasushi Itoh¹ (1. Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, 2. Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, 3. Department of Quality Assurance and Radiological Protection, National Institute of Infectious Diseases)

*Atsuko Inoue^1,2, Yukari Itakura¹, Shinji Saito¹, Yasuko Orba^1,3,4, Katsumi Maenaka^1,2,3,5,6, Hirofumi Sawa^1,3,4, Koshiro Tabata¹ (1. Institute for Vaccine Research and Development, Hokkaido University, 2. Faculty of Pharmaceutical Science, Graduate School of Life Science, Hokkaido University, 3. International Institute for Zoonosis Control, Hokkaido University, 4. One Health Research Center, Hokkaido University, 5. Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, 6. Global Station for Biosurfaces and Drug Discovery, Hokkaido University)